Jesse Seminara
About Jesse Seminara
Jesse Seminara is a Senior Manager at Bristol-Myers Squibb with extensive experience in programming development for Neuroscience and Oncology compounds.
Current Title and Role at Bristol-Myers Squibb
Jesse Seminara holds the position of Senior Manager at Bristol-Myers Squibb. In this role, he is responsible for leading both full-time and contract programming personnel in support of Oncology and Neuroscience projects. His work involves significant contributions to clinical programming development and the application of programming solutions in clinical drug development.
Professional Background at Bristol-Myers Squibb
Jesse Seminara has a long-standing career with Bristol-Myers Squibb, spanning multiple roles since 1986. Initially, he worked as a Clinical Programmer for eight years, followed by a two-year stint as Manager. Returning in 1994, he served as Senior Manager for seventeen years in Wallingford, CT. His extensive tenure demonstrates a deep commitment and significant expertise within the organization.
Education and Academic Background
Jesse Seminara graduated from the College of the Holy Cross, where he achieved a BA in Biology. His academic background provided a strong foundation for his career in clinical programming and drug development, particularly in the fields of Neuroscience and Oncology.
Expertise in Clinical Programming
With a robust background in clinical programming, Jesse Seminara has extensive experience in programming development for Neuroscience and Oncology compounds. He plays a pivotal role in the development and validation of CRO-developed statistical output and has significantly contributed to the Bristol-Myers Squibb CDISC initiative.
Leadership in Oncology and Neuroscience Projects
As Senior Manager, Jesse Seminara leads the programming team, ensuring that both full-time and contract personnel effectively support Oncology and Neuroscience projects. His leadership is critical in driving the application of programming solutions throughout various stages of clinical drug development, enhancing the efficiency and accuracy of clinical trials.